High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma

  • Admiraal R
  • van der Paardt M
  • Kobes J
  • et al.
14Citations
Citations of this article
128Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood. Prognosis for patients with metastatic disease has not improved significantly in the past decades. High-dose chemotherapy (HDC) seems to be an attractive option to treat minimal residual disease in metastatic rhabdomyosarcoma patients.

Cite

CITATION STYLE

APA

Admiraal, R., van der Paardt, M., Kobes, J., Kremer, L. C., Bisogno, G., & Merks, J. H. (2010). High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd006669.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free